News from upsher-smith laboratories, inc

Jul 14, 2014, 09:00 ET
Upsher-Smith Laboratories, Inc.  (PRNewsFoto/Upsher-Smith Laboratories, Inc.)

Upsher-Smith Announces Immediate Availability Of A Generic Equivalent To Qudexy™ XR (Topiramate) Extended-Release Capsules

 Upsher-Smith Laboratories, Inc. (Upsher-Smith), today announced the launch of Topiramate Extended-Release Capsules, the authorized generic of...

Jul 02, 2014, 09:00 ET

Upsher-Smith Announces Launch Of The First And Only Generic Transdermal Testosterone Gel Available In Three Convenient Configurations

Upsher-Smith Laboratories, Inc., today announced the launch of Testosterone Gel (1%), the generic of the newly Food and Drug Administration (FDA)...

Jun 30, 2014, 09:00 ET
Upsher-Smith Laboratories, Inc.  (PRNewsFoto/Upsher-Smith Laboratories, Inc.)

Upsher-Smith Launches Qudexy™ XR (Topiramate) Extended-Release Capsules For Treatment Of Specific Seizure Types

 Upsher-Smith Laboratories, Inc. (Upsher-Smith), today announced that Qudexy™ XR (topiramate) extended-release capsules is now available...

Jun 17, 2014, 09:00 ET
Upsher-Smith Laboratories, Inc.  (PRNewsFoto/Upsher-Smith Laboratories, Inc.)

Qudexy™ XR (Topiramate) Extended-Release Capsules Phase 3 Data Published In Epilepsia

 Results from Upsher-Smith Laboratories, Inc.'s, Phase 3 study of USL255, Qudexy™ XR (topiramate) extended-release capsules, a...

Jun 09, 2014, 17:19 ET
Upsher-Smith DIANA Award Presentation; Left to Right: John Gray (President & CEO, HDMA), Brad Leonard (Director of National Accounts, Upsher-Smith), Jim Maahs (Sr. Director, Commercial Operations, Upsher-Smith), David Neu (President, AmeriSourceBergen Drug Corp). (PRNewsFoto/Upsher-Smith Laboratories, Inc.)

Upsher-Smith Named Healthcare Distribution Management Association's Manufacturer Partner of the Year

 Upsher-Smith Laboratories, Inc. today announced that it is the recipient of a Distribution Industry Award for Notable Achievements in...

Jun 04, 2014, 14:53 ET
Upsher-Smith Laboratories, Inc.  (PRNewsFoto/Upsher-Smith Laboratories, Inc.)

Upsher-Smith Receives Final NDA Approval For Vogelxo™ (Testosterone) Gel CIII

 Upsher-Smith Laboratories, Inc., today announced that it has received final approval from the U.S. Food and Drug Administration (FDA) for its...

Apr 29, 2014, 15:00 ET
Upsher-Smith Laboratories, Inc.  (PRNewsFoto/Upsher-Smith Laboratories, Inc.)

Upsher-Smith Presents Favorable Phase I Data For USL261, A Novel Formulation Of Intranasal Midazolam, At 66th Annual Meeting of the American Academy of Neurology

 Upsher-Smith Laboratories, Inc., (Upsher-Smith) today announced that Phase I data for USL261 (investigational intranasal midazolam) in...

Apr 21, 2014, 11:30 ET
Upsher-Smith Laboratories, Inc.  (PRNewsFoto/Upsher-Smith Laboratories, Inc.)

New Data From Upsher-Smith's Epilepsy Portfolio To Be Highlighted At The 66th Annual Meeting Of The American Academy Of Neurology

 Upsher-Smith Laboratories, Inc. (Upsher-Smith), will highlight new pooled phase 1 data from studies in healthy adults comparing the adverse...

Mar 25, 2014, 10:07 ET
Upsher-Smith Laboratories, Inc.  (PRNewsFoto/Upsher-Smith Laboratories, Inc.)

Local Forest Lake Family Attends 2014 National Walk For Epilepsy® In Washington, D.C.

Upsher-Smith Laboratories, Inc. (Upsher-Smith), in partnership with the Epilepsy Foundation of Minnesota (EFMN), today announced that the Fletcher...

Mar 25, 2014, 10:04 ET
Pictured at the 2014 National Walk for Epilepsy(R): Scott Hussey, Sr. Vice President, Sales; Jordan Fletcher; Mary Melby; Callie Fletcher; Eric Hamborg, Vice President, CNS Sales; Rachael Newman; Tyler Melby; Chris Thibodeaux, Sr. Director, Therapeutic Education and Communication; Mark Evenstad, President and CEO.  (PRNewsFoto/Upsher-Smith Laboratories, Inc.)

Local Washington Township Family Attends 2014 National Walk for Epilepsy® In Washington, D.C.

Upsher-Smith Laboratories, Inc. (Upsher-Smith), in partnership with the Epilepsy Foundation of New Jersey (EFNJ), today announced that the Leaf...

Mar 24, 2014, 13:54 ET
Upsher-Smith Laboratories, Inc.  (PRNewsFoto/Upsher-Smith Laboratories, Inc.)

Upsher-Smith Divests Three Women's Health Products To Vertical Pharmaceuticals

Upsher-Smith Laboratories, Inc. (Upsher-Smith), a fully integrated pharmaceutical company committed to the development of new treatments for...

Mar 12, 2014, 11:22 ET
Qudexy XR (topiramate) extended-release capsules product logo.  (PRNewsFoto/Upsher-Smith Laboratories, Inc.)

Upsher-Smith Receives FDA Approval For Qudexy™ XR (Topiramate) Extended-Release Capsules

 Upsher-Smith Laboratories, Inc. (Upsher-Smith), today announced it received approval on March 11, 2014 from the U.S. Food and Drug...

Mar 04, 2014, 10:30 ET

American Heart Month 2014: Committing to a Year of Heart Health

 February has passed and with its close comes the end of American Heart Month. But the end of the month should not be the end of...

Mar 03, 2014, 09:00 ET

Upsher-Smith Launches Online Community Resource Program For Patients Living With Seizure Clusters

Upsher-Smith Laboratories, Inc. (Upsher-Smith) today announced a new educational program created for patients living with seizure clusters, as well...

Jan 13, 2014, 09:00 ET
Upsher-Smith Laboratories, Inc.  (PRNewsFoto/Upsher-Smith Laboratories, Inc.)

Upsher-Smith Honors 42 Pharmacists Nationwide For Excellence In Innovation

 Upsher-Smith Laboratories, Inc. (Upsher-Smith), is pleased to honor the 2013 recipients of the National Alliance of State Pharmacy...

Dec 10, 2013, 09:00 ET
Upsher-Smith Laboratories, Inc.  (PRNewsFoto/Upsher-Smith Laboratories, Inc.)

Upsher-Smith Presents New Data On The PK Equivalence Of USL255 (Extended-Release Topiramate) When Sprinkled On Food Or Swallowed Intact

 Upsher-Smith Laboratories, Inc. (Upsher-Smith), today announced the presentation of new Phase 1 data showing that USL255 (extended-release...

Dec 09, 2013, 09:00 ET
Upsher-Smith Laboratories, Inc.  (PRNewsFoto/Upsher-Smith Laboratories, Inc.)

Upsher-Smith Debuts Positive Results From Global Phase 3 Study Evaluating USL255 (extended-release topiramate) In Epilepsy Patients With Refractory Partial-Onset Seizures

 Upsher-Smith Laboratories, Inc. (Upsher-Smith) today presented results from its global Phase 3 (PREVAIL) study of USL255 (extended-release...

Dec 04, 2013, 10:00 ET

Industry Expert's Advice on Selecting a Dietary Supplement Niacin for Heart Health: Only Reach for Nicotinic Acid Produced by a Trusted Manufacturer

Dietary supplements are dominating the shelves of pharmacy retailers, with brands vying for the attention of health-conscious consumers. In fact,...

Nov 18, 2013, 09:00 ET
Upsher-Smith Laboratories, Inc.  (PRNewsFoto/Upsher-Smith Laboratories, Inc.)

Upsher-Smith To Present New Research On USL255 (Extended-Release Topiramate) At 2013 American Epilepsy Society Annual Meeting

 Upsher-Smith Laboratories, Inc. (Upsher-Smith), today announced that it will present new research from its epilepsy clinical development...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

Research and Markets
ReportBuyer
Investor-Edge